Thorsten Graef und Abbvie Person-Info 

( Ich bin Thorsten Graef)
(1 - 3 von 9
)

IMBRUVICA® (ibrutinib) Pooled Analysis Suggests Benefit ...AbbVie News Center

news.abbvie.com
AP — "IMBRUVICA continues to provide a beneficial treatment option for patients with relapsed/refractory mantle cell lymphoma," said Thorsten Graef, AP — "IMBRUVICA continues to provide a beneficial treatment option for patients with relapsed/refractory mantle cell lymphoma," said Thorsten Graef, ...
+1